CompletedNCT00247624
Sleep medicine and fluoxetine for depression with insomnia
About this title
Read the official source — NCT00247624Medication studyAges 18–70United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Winston-SalemSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateOctober 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00247624
- Official title
Show the full official title
Hypnotics in the Treatment of Psychiatric Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Winston-Salem
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Wake Forest University Health Sciences, a university.
Did this study involve medication?
Yes. The study involved medication, including Eszopiclone, Fluoxetine and Placebo.
Who was this study for?
Listed age limits: 18 years to 70 years.
